Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $686 | $378 | $639 | $166 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $86 | $70 | $52 |
| Inventory | $111 | $85 | $67 | $67 |
| Other Curr. Assets | $120 | $99 | $100 | $74 |
| Total Curr. Assets | $917 | $648 | $876 | $359 |
| Property Plant & Equip (Net) | $2 | $2,288 | $2,268 | $2,226 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $10 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,746 | $14 | $14 | $14 |
| Total NC Assets | $1,758 | $2,302 | $2,282 | $2,240 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,676 | $2,951 | $3,158 | $2,598 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $1,567 | $909 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $282 | $350 | $0 |
| Other Curr. Liab. | $1,587 | $1,700 | $0 | $1,185 |
| Total Curr. Liab. | $1,587 | $1,983 | $1,917 | $2,094 |
| LT Debt | $29 | $40 | $40 | $40 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $14 | $14 | $14 |
| Total NC Liab. | $39 | $54 | $54 | $54 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,626 | $2,037 | $1,971 | $2,148 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9,139 | $10,944 | $10,659 | $9,139 |
| Retained Earnings | -$9,822 | -$12,197 | -$11,653 | -$10,835 |
| AOCI | $9 | $17 | $30 | $21 |
| Other Equity | $1,724 | $2,150 | $2,150 | $2,125 |
| Total Equity | $1,050 | $914 | $1,186 | $450 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,676 | $2,951 | $3,158 | $2,598 |
| Net Debt | -$657 | -$338 | -$599 | -$126 |